NYSE · THC
Tenet Healthcare Corporation
$270.57+$2.07 (+0.77%)
Tenet Healthcare Corporation’s quoted price sits in the upper half of its reported 52-week range, 4.41% below the high.
Loading market information…
NASDAQ · NUTX · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Nutex Health, Inc.’s quoted price sits in the upper half of its reported 52-week range, 7.1% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Nutex Health, Inc.’s next earnings report is currently expected on Nov 5, 2026, with estimated earnings per share of $5.54. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Nutex Health, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Nutex Health, Inc. functions as a technology-powered enterprise delivering healthcare services, structured into two key segments: its Hospital division and its Population Health Management division. The Hospital division is tasked with developing and overseeing various healthcare models, encompassing micro-hospitals, specialized medical centers, and hospital outpatient facilities. This segment currently owns and operates 21 locations spanning eight different states. Meanwhile, the Population Health Management division establishes and manages provider networks, such as independent physician associations. Additionally, its management services organizations furnish administrative, operational, and support assistance to its associated hospitals and physician groups. A proprietary, cloud-based technology platform within this division is crucial; it aggregates patient and provider data from multiple information systems, settings, and sources to construct a holistic view, thereby enabling more effective care delivery. The company maintains its corporate headquarters in Houston, Texas.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 02:24 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q1 2025 | May 13, 2025 | $2.56-15.79% vs estimate | $211.79M+57.77% vs estimate |
|---|
| Q4 2024 | Mar 31, 2025 | $11.12+9,366.67% vs estimate | $257.62M+217.56% vs estimate |
|---|
| Q3 2024 | Nov 8, 2024 | -$1.72-616.67% vs estimate | $78.79M+7.61% vs estimate |
|---|
THE ANALYST VIEW
5 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
Consensus coverage: 1 contributors · Median target $310.00.
Average targets in published notes for each window. These figures use a different sample from the consensus above.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$270.57+$2.07 (+0.77%)
Tenet Healthcare Corporation’s quoted price sits in the upper half of its reported 52-week range, 4.41% below the high.
$131.49+$9.41 (+7.7%)
Encompass Health Corporation’s quoted price sits in the upper half of its reported 52-week range, 1.69% below the high.
$176.61+$4.43 (+2.57%)
Universal Health Services, Inc.’s quoted price sits in the lower half of its reported 52-week range, 28.3% below the high.
$41.25+$0.66 (+1.63%)
Concentra Group Holdings Parent, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.29% below the high.
$23.21-$0.03 (-0.13%)
Surgery Partners, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.68% below the high.
$36.62-$0.05 (-0.14%)
Astrana Health, Inc.’s quoted price sits in the upper half of its reported 52-week range, 29.03% below the high.
$12.30+$0.37 (+3.1%)
Ardent Health Inc.’s quoted price sits in the upper half of its reported 52-week range, 18.49% below the high.
$85.94-$5.06 (-5.56%)
Agilon Health, Inc.’s quoted price sits in the upper half of its reported 52-week range, 35.4% below the high.
